Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-037939
Filing Date
2019-10-25
Accepted
2019-10-25 17:04:54
Documents
3
Effectiveness Date
2019-10-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A abio-defa14a_20191028.htm DEFA14A 32508
2 GRAPHIC gd1prvobrjl1000001.jpg GRAPHIC 82092
3 GRAPHIC gd1prvobrjl1000002.jpg GRAPHIC 58676
  Complete submission text file 0001564590-19-037939.txt   227864
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 191170628
SIC: 2835 In Vitro & In Vivo Diagnostic Substances